Data updated: Jun 28, 2026
Malaria Clinical Trial Landscape
Malaria is being studied across 598 clinical trials registered since 2008, with 71 programs currently active. The competitive pipeline includes 14 active Phase 3 trials, 19 active Phase 2 trials, and 21 active Phase 1 trials.
Top industry sponsors include GSK, Sanaria Inc., Novartis.
Trial activity
71 active / 598 total since 2008
Active by phase 14 Ph3 / 129 19 Ph2 / 152 21 Ph1 / 195 17 Ph4 / 122
Sponsor activity
Who is running trials now — green active, blue completed, red failed/terminated.
Sorted by active Active Done Failed
GSK 6 26 1
Sanaria Inc. 2 24 1
Novartis 1 17 2
Serum Institute of India Pvt. Ltd. 1 1 0
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd 1 0 1
Zydus Lifesciences Limited 1 1 0
Eisai Inc. 1 0 0
Sanofi 0 4 4
Pfizer 0 6 0
sigma-tau i.f.r. S.p.A. 0 4 0
How the field has grown
New-trial starts peaked in 2016 (43 registered); 2025 saw 27. The right-hand chart shows median Phase 3 enrollment by start year — the number in parentheses is that year's Phase 3 trial count (52 in total), so single-trial years (and years with no Phase 3 starts) are obvious. Both are by trial start date; the current year is partial.
New trials started by year
2016 43
2017 27
2018 29
2019 28
2020 18
2021 27
2022 28
2023 26
2024 27
2025 27
2026 21
TheraRadar.com
Median Phase 3 enrollment by start year
2016 (5) 1,049
2017 (4) 651
2018 (7) 310
2019 (8) 782
2020 (5) 2,583
2021 (6) 487
2022 (3) 1,172
2023 (1) 2,400
2024 (8) 1,405
2025 (4) 1,595
2026 (1) 1,019
TheraRadar.com
Full trial pipeline
Every active and completed trial across Phase 1–4, with enrollment analytics. Sortable, filterable, exportable with Pro.
NCT04978272 ACTIVE NOT RECRUITING
Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP)
Grant Dorsey, M.D, Ph.D. n=924
NCT06923592 RECRUITING
Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar
London School of Hygiene and Tropical Medicine n=19,200
NCT07468526 NOT YET RECRUITING
An Ultra-short Course of Primaquine for the Radical Cure of Vivax Malaria
Menzies School of Health Research n=1,019
NCT04704830 ACTIVE NOT RECRUITING
R21/Matrix-M in African Children Against Clinical Malaria
University of Oxford n=4,800
NCT04009343 ACTIVE NOT RECRUITING
Pharmacokinetics and Pharmacodynamics of the Gametocytocidal and Post-treatment Chemoprotective Effects of Antimalarials
Johns Hopkins Bloomberg School of Public Health n=182
NCT06962319 RECRUITING
Safety of Antimalarials in the FIRst trimEster
Liverpool School of Tropical Medicine n=1,510
NCT05951595 RECRUITING
A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and Tolerable as Combinations of 2 Medicines
University of Oxford n=1,680
NCT05690841 RECRUITING
FocaL Mass Drug Administration for Vivax Malaria Elimination
University of California, San Francisco n=7,530
NCT06666491 RECRUITING
An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older
GlaxoSmithKline n=300
NCT07082205 RECRUITING
Monoclonal Antibodies in Children With Severe Anaemia or Severe Malaria to Prevent Malaria After Hospital Discharge
Liverpool School of Tropical Medicine n=398
NCT06148792 RECRUITING
A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria
Menzies School of Health Research n=1,090
NCT05426434 ACTIVE NOT RECRUITING
Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy
Menzies School of Health Research n=1,172
NCT06516042 ACTIVE NOT RECRUITING
Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopia
PATH n=10,350
NCT06578572 RECRUITING
Seasonal R21 Mass Vaccination for Malaria Elimination
London School of Hygiene and Tropical Medicine n=16,200
NCT05842954 COMPLETED
Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum Malaria
Novartis Pharmaceuticals n=1,720
NCT04300309 TERMINATED
Pharmacokinetics, Safety, Tolerability and Efficacy of a New Artemether-lumefantrine Dispersible Tablet in Infants and Neonates <5 kg Body Weight With Acute Uncomplicated Plasmodium Falciparum Malaria
Novartis Pharmaceuticals n=28
NCT03923725 COMPLETED
A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combina-tions of 2 Anti-malarial Drugs.
University of Oxford n=2,583
NCT04336189 COMPLETED
Optimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in Uganda
Grant Dorsey, M.D, Ph.D. n=2,757
NCT03967054 COMPLETED
Repeat Ivermectin Mass Drug Administrations for MALaria Control II
Brian Foy n=4,124
NCT03300648 COMPLETED
Treating Brain Swelling in Pediatric Cerebral Malaria
Michigan State University n=57
NCT04966702 COMPLETED
Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA)
Barcelona Institute for Global Health n=48,145
NCT06166498 COMPLETED
Parasite Clearance and Protection From Infection (PCPI) in Zambia
London School of Hygiene and Tropical Medicine n=600
NCT06173206 COMPLETED
Parasite Clearance and Protection From Infection (PCPI) in Cameroon
London School of Hygiene and Tropical Medicine n=902
NCT02163447 COMPLETED
Reducing the Burden of Malaria in HIV-uninfected Pregnant Women and Infants
Grant Dorsey, M.D, Ph.D. n=300
NCT03640403 COMPLETED
Effectiveness and Safety of Intermittent Preventive Treatment for Malaria Using Either Dihydroartemisinin-piperaquine or Artesunate-amodiaquine in Reducing Malaria Related Morbidities and Improving Cognitive Ability in School-aged Children in Tanzania
National Institute for Medical Research, Tanzania n=1,555
NCT04411836 COMPLETED
Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine
Menzies School of Health Research n=960
NCT03671109 COMPLETED
Improving Maternal heAlth by Reducing Malaria in African HIV Women
Barcelona Institute for Global Health n=666
NCT03074435 COMPLETED
Insecticide Resistance Management in Burkina Faso and Côte D'Ivoire
Institut de Recherche pour le Developpement n=15,776
NCT04319380 COMPLETED
Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) Extension Study
London School of Hygiene and Tropical Medicine n=5,098
NCT06179732 COMPLETED
Field Evaluations of Innovative Tools for Vector-borne Disease Control in Conflict-affected Communities
The Mentor Initiative n=2,400
NCT00852371 COMPLETED
Intermittent Preventive Treatment of Malaria in Schoolchildren
London School of Hygiene and Tropical Medicine n=780
NCT03939104 COMPLETED
A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combinations of 2 Anti-malarial Drugs (Asia)
University of Oxford n=103
NCT04695197 COMPLETED
Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso
Liverpool School of Tropical Medicine n=143
NCT04844099 COMPLETED
Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Sickle Cell Anaemia
Liverpool School of Tropical Medicine n=723
NCT04158713 COMPLETED
Improving PRegnancy Outcomes With PReVEntive Therapy in Africa-2 (IMPROVE-2)
Liverpool School of Tropical Medicine n=898
NCT03208907 COMPLETED
DHA-PQP vs Chloroquine and Primaquine for Radical Cure of Vivax Malaria in Brazil
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado n=419
NCT04189744 COMPLETED
The ASPIRE Trial - Aiming for Safe Pregnancies by Reducing Malaria and Infections of the Reproductive Tract
London School of Hygiene and Tropical Medicine n=5,436
NCT05232227 WITHDRAWN
Primaquine Double Dose for Radical Cure of Plasmodium Vivax in Colombia
University of California, San Francisco
NCT04147546 COMPLETED
Additional Screening With Sensitives RDTs and Malaria
Institut de Recherche en Sciences de la Sante, Burkina Faso n=340
NCT04783051 COMPLETED
Comparison of ISTp- PYRAMAX-US-RDT to IPTp-SP to Prevent Malaria in Pregnant Women in DRC (ULTRAPYRAPREG)
University of Kinshasa n=250
NCT03355664 COMPLETED
Study to Compare the Triple ACT AL+AQ With the ACT AL in Cambodia and Vietnam
University of Oxford n=310
NCT03208179 COMPLETED
Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa
Liverpool School of Tropical Medicine n=4,680
NCT05192265 COMPLETED
Efficacy and Safety of Pyronaridine-Artesunate Versus Artemether-Lumefantrine
University of Ibadan n=172
NCT03143218 COMPLETED
Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ)
London School of Hygiene and Tropical Medicine n=5,920
NCT01054248 COMPLETED
Randomised Trial of 3 Artemisinin Combination Therapy for Malaria in Pregnancy
University of Oxford n=511
NCT03576313 COMPLETED
Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination
London School of Hygiene and Tropical Medicine n=4,939
NCT03452475 COMPLETED
Comparison of Arterolane-piperaquine Versus Arterolane-piperaquine+Mefloquine Versus Artemether-lumefantrine in Kenyan Children
University of Oxford n=219
NCT02699099 COMPLETED
Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.
GlaxoSmithKline n=699
NCT02315690 COMPLETED
Evaluation of Reactive Focal Mass Drug Administration for Malaria Elimination in Swaziland
University of California, San Francisco n=4,000
NCT03009526 COMPLETED
Efficacy and Safety of IPTp-DP Versus IPTp-SP in Malawi
Kamuzu University of Health Sciences n=602
NCT02793622 COMPLETED
Prevention of Malaria in HIV-uninfected Pregnant Women and Infants
University of California, San Francisco n=782
NCT01746199 COMPLETED
Efficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance in Plasmodium Falciparum
Institut Pasteur n=193
NCT02802501 COMPLETED
Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria
GlaxoSmithKline n=150
NCT02610400 COMPLETED
Evaluation of Reactive Focal Mass Drug Administration (rfMDA) +/- Reactive Focal Vector Control (RAVC) in Namibia
University of California, San Francisco n=9,845
NCT02671175 COMPLETED
Post-discharge Malaria Chemoprevention(PMC) Study
Liverpool School of Tropical Medicine n=1,049
NCT03128515 COMPLETED
Optimizing Hydroxyurea Therapy in Children With SCA In Malaria Endemic Areas
Indiana University n=187
NCT04049916 COMPLETED
Pyronaridine-artesunate With Low Dose Primaquine for Preventing P. Falciparum Transmission
London School of Hygiene and Tropical Medicine n=100
NCT03056391 COMPLETED
Effect of Paracetamol on Renal Function in Plasmodium Knowlesi Malaria
Menzies School of Health Research n=360
NCT02207816 COMPLETED
An Extension to Study MALARIA-055 PRI (NCT00866619) to Evaluate the Long-term Efficacy, Safety and Immunogenicity of GSK Biologicals' Candidate Malaria Vaccine in Infants and Children in Africa
GlaxoSmithKline n=3,084
NCT00866619 COMPLETED
Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in Africa
GlaxoSmithKline n=15,459
NCT01345240 COMPLETED
Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)
GlaxoSmithKline n=705
NCT00993031 COMPLETED
Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women
University of California, San Francisco n=389
NCT02282293 COMPLETED
Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2)
University of California, San Francisco n=200
NCT02533336 TERMINATED
The Effectiveness of Non-Pyrethroid Insecticide-Treated Durable Wall Liners as a Method for Malaria Control in Endemic Rural Tanzania
National Institute for Medical Research, Tanzania n=4,917
NCT01148459 COMPLETED
Safety and Immunogenicity of GSK Biologicals' Investigational Malaria Vaccine in HIV Infected Infants and Children
GlaxoSmithKline n=200
NCT02509481 COMPLETED
Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study
Colorado State University n=2,712
NCT00978068 COMPLETED
HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children
University of California, San Francisco n=176
NCT01976416 COMPLETED
Novel Use Of Hydroxyurea in an African Region With Malaria
Indiana University n=208
NCT01845701 COMPLETED
Artemisinin-Based Antimalarial Combinations and Clinical Response in Cameroon
University of Yaounde 1 n=720
NCT02020330 COMPLETED
Optimising Operational Use of Artemether-lumefantrine Comparing 3 Day Versus 5 Day
University of Oxford n=150
NCT00936767 WITHDRAWN
Artemisone for the Treatment of Uncomplicated Falciparum Malaria in Western Cambodia
University of Oxford
NCT01323972 COMPLETED
Consistency of Immunogenicity and Non Inferiority of GSK Biologicals' Candidate Malaria Vaccine Lots in Children
GlaxoSmithKline n=327
NCT02216123 COMPLETED
Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria
GlaxoSmithKline n=251
NCT02453308 COMPLETED
A Study by the Tracking Resistance to Artemisinin Collaboration (TRAC)
University of Oxford n=1,110
NCT01838902 COMPLETED
Primaquine's Gametocytocidal Efficacy in Malaria Asymptomatic Carriers
London School of Hygiene and Tropical Medicine n=467
NCT02211729 COMPLETED
A Trial of Seasonal Malaria Chemoprevention Plus Azithromycin in African Children
London School of Hygiene and Tropical Medicine n=22,090
NCT02698748 COMPLETED
Evaluating the Role of Chloroquine for Malaria Elimination
Centro de Investigacao em Saude de Manhica n=75
NCT02411994 COMPLETED
Pyronaridine-artesunate and Artemether-lumefantrine for the Treatment of Paediatric Malaria
Royal Tropical Institute n=197
NCT02001012 COMPLETED
P. Knowlesi Trial of Artemether-lumefantrine vs Chloroquine
Menzies School of Health Research n=123
NCT02083380 COMPLETED
Phase II Efficacy Study of Artefenomel & Piperaquine in Adults & Children With P. Falciparum Malaria.
Medicines for Malaria Venture n=448
NCT00944840 COMPLETED
Intermittent Preventive Treatment (IPTc) and Home Based Management of Malaria (HMM)in The Gambia
London School of Hygiene and Tropical Medicine n=1,312
NCT01443130 COMPLETED
Chloroquine for Malaria in Pregnancy
National Institute of Allergy and Infectious Diseases (NIAID) n=900
NCT02987270 COMPLETED
Evaluation of Community-based Mass Screening and Treatment for Malaria in Western Kenya
Simon Kariuki n=90,000
NCT02974348 COMPLETED
Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa
University of Bamenda n=300
NCT00694694 COMPLETED
Azithromycin + Artesunate v Artemether-lumefantrine in Uncomplicated Malaria.
London School of Hygiene and Tropical Medicine n=261
NCT02654730 TERMINATED
Evaluation of the Safety of Primaquine in Combination With Dihydroartemisinin-piperaquine in G6PD Deficient Males in The Gambia
London School of Hygiene and Tropical Medicine n=61
NCT02878265 COMPLETED
The Effect of Vitamin A With and Without Zinc and Multivitamin Supplementation on Malaria Morbidity in Ghanaian Children
University of Ghana n=547
NCT01640574 COMPLETED
Comparison Between 7 and 14 Day Primaquine Combined With Dihydroartemisinin-piperaquine or 3 Day Chloroquine Radical Cure of P. Vivax (BPD)
University of Oxford n=680
NCT00852423 COMPLETED
Safe and Efficacious Artemisinin-based Combination Treatments for African Pregnant Women With Malaria
Institute of Tropical Medicine, Belgium n=3,428
NCT02605720 COMPLETED
Cardiac Safety of Repeated Doses of Dihydroartemisinin-Piperaquine for the Use in Mass Treatment Campaigns
Lihir Medical Centre n=78
NCT02691910 COMPLETED
Efficacy of Chloroquine (CQ) Alone Compared to Concomitant CQ and Primaquine for Plasmodium Vivax Infection
Oswaldo Cruz Foundation n=204
NCT01231113 COMPLETED
Efficacy,Safety and Tolerability of Dihydroartemisinin-Piperaquine for Uncomplicated Malaria in Pregnancy in Ghana
Kwame Nkrumah University of Science and Technology n=417
NCT02174900 COMPLETED
Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM)
London School of Hygiene and Tropical Medicine n=70
NCT01589289 COMPLETED
Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC
Institute of Tropical Medicine, Belgium n=352
NCT00711906 TERMINATED
Daily Co-trimoxazole Prophylaxis to Prevent Malaria in Pregnancy
Institute of Tropical Medicine, Belgium n=352
NCT02259426 COMPLETED
Dihydroartemisinin-piperaquine With Low Dose Primaquine to Reduce Malaria Transmission
London School of Hygiene and Tropical Medicine n=120
NCT00948896 COMPLETED
Chemopreventive Therapy for Malaria in Ugandan Children
University of California, San Francisco n=600
NCT01785979 WITHDRAWN
Prednisone Plus Chloroquine for the Treatment of Hyper-reactive Malarial Splenomegaly
Lihir Medical Centre
NCT02461186 WITHDRAWN
Arterolane-PQP Versus DHA-PQP in Uncomplicated Falciparum Malaria in Eastern Myanmar
University of Oxford
NCT02563704 COMPLETED
A Trial of the Efficacy of Artesunate and Three Quinine Regimens in the Treatment of Severe Malaria in Children at the Ebolowa Regional Hospital - Cameroon
University of Yaounde 1 n=238
NCT01935882 COMPLETED
Low Dose Primaquine for Clearance of Gametocytes
London School of Hygiene and Tropical Medicine n=360
NCT01619878 COMPLETED
Efficacy, Safety and Pharmacokinetics of Artemether-lumefantrine Dispersible Tablet in the Treatment of Malaria in Infants < 5 kg
Novartis Pharmaceuticals n=20
NCT01144702 COMPLETED
Effectiveness of the Association Artesunate and Mefloquine in the Treatment of Malaria by Plasmodium Falciparum
Oswaldo Cruz Foundation n=163
NCT01708876 COMPLETED
P. Knowlesi Trial of Artesunate-mefloquine Versus Chloroquine
Menzies School of Health Research n=250
NCT01043796 COMPLETED
Evaluation of Insecticide Treated Nets and Wall Liners for the Prevention of Malaria
Centers for Disease Control and Prevention n=1,730
NCT01374581 COMPLETED
Impact of Artemisinin-based Combination Therapy and Quinine on Treatment Failure and Resistance in Uncomplicated Malaria
Universiteit Antwerpen n=2,117
NCT00677833 COMPLETED
Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated P. Falciparum Malaria In Children In Africa
Pfizer n=361
NCT01810731 WITHDRAWN
Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya
Centers for Disease Control and Prevention
NCT01916954 COMPLETED
Comparison of Two Regimens of Artemether-lumefantrine for the Treatment of Malaria in Pregnancy
University of Oxford n=96
NCT01258049 COMPLETED
Superiority of ArTiMist Versus Quinine in Children With Severe Malaria
Proto Pharma Ltd n=151
NCT01939886 COMPLETED
Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy 2 (TRANSACT2)
London School of Hygiene and Tropical Medicine n=219
NCT01053325 COMPLETED
Establishing Effectiveness of Daily Co-trimoxazole Prophylaxis For Prevention of Malaria in Pregnancy
Institute of Tropical Medicine, Belgium n=848
NCT01288820 COMPLETED
Study of ACTs Plus Primaquine for Uncomplicated Plasmodium Vivax Malaria
University of Oxford n=331
NCT01378286 COMPLETED
Efficacy and Tolerability of Artesunate Amodiaquine Versus Chloroquine in the Treatment of Uncomplicated Plasmodium Vivax Malaria
Sanofi n=380
NCT01365598 COMPLETED
Evaluation of the Gametocytocidal Efficacy and Safety of Primaquine in Uncomplicated Falciparum Malaria in Uganda
London School of Hygiene and Tropical Medicine n=468
NCT01231880 COMPLETED
School Based Malaria Control in Ugandan Schoolchildren
Makerere University n=740
NCT01136850 COMPLETED
Intermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New Guinea
University of Melbourne n=2,793
NCT01782001 COMPLETED
Evaluation of Vitamin A and Zinc Supplementation on Malarial Morbidity
Kintampo Health Research Centre, Ghana n=200
NCT00970879 COMPLETED
Prevention of Pregnancy-associated Malaria in HIV-infected Women: Cotrimoxazole Prophylaxis Versus Mefloquine
Institut de Recherche pour le Developpement n=430
NCT01449045 COMPLETED
Trial of Malaria Seasonal IPTc Combined With Community Case Management
Cheikh Anta Diop University, Senegal n=4,554
NCT01082718 WITHDRAWN
Pharmacokinetics of Mefloquine-Artesunate in Pregnant Women With Uncomplicated Plasmodium Falciparum Infection
Centers for Disease Control and Prevention
NCT01082705 COMPLETED
Assessing the Efficacy of Artemisinin Combination Therapies for Treatment of Uncomplicated Malaria Infection in Children
Centers for Disease Control and Prevention n=323
NCT01065116 COMPLETED
Artemether-Lumefantrine (AL) Unit Dose Pre-packs Versus Blister Packs
Malaria Consortium, Uganda n=920
NCT00941785 COMPLETED
Dihydroartemisinin (DHA)-Piperaquine for IPT to Prevent Malaria in Children in Burkina Faso
London School of Hygiene and Tropical Medicine n=1,500
NCT00701961 COMPLETED
Pharmacokinetic of Mefloquine-Artesunate in Plasmodium Falciparum Malaria Infection in Pregnancy
Institute of Tropical Medicine, Belgium n=48
Data: ClinicalTrials.gov · Trials registered 2008 onwards · Industry sponsors only